CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale President and COO sold 626 shares at $261.20 ($163,512)
- 4 Open-market sale SVP, General Counsel sold 428 shares at $257.64 ($110,268)
- 4 Open-market sale Chief Executive Officer sold 1,949 shares at an average $257.24 ($501,355)
- 4 Grant or award Director acquired 99,892 shares (grant or award)
- 4 Grant or award Director acquired 18,980 shares (grant or award)
- 4 Grant or award Director acquired 18,980 shares (grant or award)
- 4 Grant or award Director acquired 18,980 shares (grant or award)
- 4 Grant or award Director acquired 18,980 shares (grant or award)
- 4 Grant or award Director acquired 18,980 shares (grant or award)
- 4 Grant or award Director acquired 18,980 shares (grant or award)
- 4 Grant or award Director acquired 18,980 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 37,960 shares (grant or award)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 64 · 1,277 filings